Tafinlar 75 Mg Capsules For Supplement Diet, Depression, Neuropathy Pain, Migraine, Pain Killer, Vitamin D3 Defecency

₹ 75,000 - ₹ 1 Lakh / Piece

Brand NameAayurwia
Packaging TypeWhite
FormCapsules
SpecialitySafe Packing, Low-Fat, Long Shelf Life, Good Quality, Reduce Inflammation, Maintain Healthy Cholesterol Levels, Lower Blood Sugar Levels
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Trader, Buying House
Preferred Buyer Location All over the world

Company Information

4.0/5

Member Since 4 Years
Nature of Business Retailer
GST No. 09AANFV2055P1ZE

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Brand NameAayurwia
Packaging TypeWhite
FormCapsules
SpecialitySafe Packing, Low-Fat, Long Shelf Life, Good Quality, Reduce Inflammation, Maintain Healthy Cholesterol Levels, Lower Blood Sugar Levels
ApplicationSupplement Diet, For Depression, For Neuropathy Pain, For Migraine, For Pain Killer, For Vitamin D3 Defecency, In Vitamin Defecency, Skin Care, Weight Loss
GradeMedicine Grade
CertificationISO-9001: 2008 Certified

Dabrafenib Tafinlar 75 Mg, Novartis, 120 Capsule

Product Specifications

Packaging Size

bottle

Brand

tafinal dabrafenib 75 mg

Treatment

cancer

Prescription/Non prescription

Prescription

Tablet

Shelf life

Therapeutic Uses

to treat a type of skin cancer (melanoma).It is also used with trametinib to treat thyroid cancer.

Minimum Order Quantity

100 Bottle

Delivery Time

4-5 working days

Packaging Details

Guidance for the administration and management of Koselugo in the treatment of pediatric patients with NF1 PN based on results from SPRINT Phase II Stratum 1, a landmark study coordinated with the National Cancer Institute (NCI).1,2 Koselugo can be used in patients regardless of whether or not they have had previous surgery for PN.2

Product Description

Dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation. Treatment with dabrafenib should be initiated and supervised by a qualified physician experienced in the use of anticancer medicinal products.